Document is current
Any future updates will be listed below
-
Authors
Kanemitsu, Yoshihiro
Fukumitsu, Kensuke
Kurokawa, Ryota
Akamatsu, Taisuke
Fukuda, Satoshi
Ito, Yutaka
Amakusa, Yuki
Suzuki, Tatsuro
Ito, Keima
Mori, Yuta
Uemura, Takehiro
Tajiri, Tomoko
Ohkubo, Hirotsugu
Shirai, Toshihiro
Niimi, Akio
-
Funding
Funding for this research was provided by:
a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government (20K17220)
- License Information
-
More Information
Article History
Received: 2 August 2024
Accepted: 26 November 2024
First Online: 28 November 2024
Declarations
:
: There is no conflict of interest in the submitted work.　The authors have competing interests outside the submitted work. Y.K. received research grants from MSD life foundation and personal fees from GSK, Novartis Pharma, AstraZeneca, Sanofi, and Kyorin. K.F. received research grants from Novartis Pharma and GSK. S.F. received personal fees from AstraZeneca and Eli Lilly. H.O. received a research grant from Boehringer Ingelheim. A.N. reports personal fees from Astellas, AstraZeneca, Kyorin, GSK, MSD, Shionogi, Bayer, Sanofi, Taiho, and Boehringer Ingelheim, and research grants from Astellas, Kyorin, Boehringer Ingelheim, Novartis, MSD, Daiichi Sankyo, Taiho, Teijin, Ono, Takeda, and Sanofi Pharmaceutical. R.K., T. A., Y.I., Y. A., T. S., K.I., Y. M., T. U., T.T., or T.S. did not receive any grants or personal fees.
: This study was approved by the ethics committee of Nagoya City University (60-18-0012) and registered in the UMIN Clinical Trials Registry (Registry ID UMIN000032497). Written informed consent was obtained from all participants. All methods were performed in accordance with the Declaration of Helsinki.
